ima_daily5min

Intel's capital expenditure increases, ASML and ASMI usher in deterministic benefits (Morgan Stanley)

2026-07-26·ima-daily5min-0726-02-a5f22316db

Street Signal | Intel's capital expenditure increases, ASML and ASMI usher in deterministic benefits (Morgan Stanley)

Intel has raised its 2026 capital expenditure outlook to over US$20 billion due to strong demand, and is focusing on investment in advanced process equipment. It expects equipment expenditure to increase by 40% year-on-year that year, and will rise significantly the following year.

ASML and ASMI, as core equipment suppliers accounting for more than 10% of Intel's history, will benefit significantly. ASMI's 14A node addressable market has expanded by about 40%, and ASML's EUV tool demand is earlier than expected.

While Morgan Stanley did not adjust its existing model, it noted that the developments confirmed the positive fundamentals for both suppliers.

The logic behind it is that Intel is forced to increase investment in the AI era to catch up with TSMC, and its capital expenditures directly translate into demand for high-end lithography machines and deposition equipment.

The market may have some expectations for this, but the strong growth in equipment spending (40% YoY) and the market expansion brought about by the 14A node are new incremental information. The potential trading implication is that this provides ASML and ASMI with support for near-term earnings upgrades.

One-sentence conclusion: Intel's aggressive capital expenditure plan has opened up new growth space for ASML and ASMI, especially ASMI's significant expansion in the 14A node addressable market, and earnings are expected to usher in an upward adjustment cycle.

Good/bad: Good for ASML and ASMI; for Intel itself, it needs to be seen whether the high investment can bring returns. The increase in equipment spending exceeded expectations and may not have been fully digested by the market. Catalysts:

1) Further guidance on capital expenditures in Intel’s subsequent financial report;

2) Order data and management comments from ASML and ASMI;

3) Public information on the 14A node equipment procurement contract.

Full text

Intel's capital expenditure increases, ASML and ASMI usher in deterministic benefits (Morgan Stanley)

Intel has raised its 2026 capital expenditure outlook to over US$20 billion due to strong demand, and is focusing on investment in advanced process equipment.

Intel has raised its 2026 capital expenditure outlook to over US$20 billion due to strong demand, and is focusing on investment in advanced process equipment. It expects equipment expenditure to increase by 40% year-on-year that year, and will rise significantly the following year. ASML and ASMI, as core equipment suppliers accounting for more than 10% of Intel's history, will benefit significantly. ASMI's 14A node addressable market has expanded by about 40%, and ASML's EUV tool demand is earlier than expected. While Morgan Stanley did not adjust its existing model, it noted that the developments confirmed the positive fundamentals for both suppliers. The logic behind it is that Intel is forced to increase investment in the AI era to catch up with TSMC, and its capital expenditures directly translate into demand for high-end lithography machines and deposition equipment. The market may have some expectations for this, but the strong growth in equipment spending (40% YoY) and the market expansion brought about by the 14A node are new incremental information. The potential trading implication is that this provides ASML and ASMI with support for near-term earnings upgrades. One-sentence conclusion: Intel's aggressive capital expenditure plan has opened up new growth space for ASML and ASMI, especially ASMI's significant expansion in the 14A node addressable market, and earnings are expected to usher in an upward adjustment cycle. Good/bad: Good for ASML and ASMI; for Intel itself, it needs to be seen whether the high investment can bring returns. The increase in equipment spending exceeded expectations and may not have been fully digested by the market. Catalysts: 1) Further guidance on capital expenditures in Intel’s subsequent financial report; 2) Order data and management comments from ASML and ASMI; 3) Public information on the 14A node equipment procurement contract.

← Back to archive